jean philippe BORGES, Author at Cancéropôle Grand sud Ouest

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)
Galerie
Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)

article du mois

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)

Article du mois de septembre 2026 - proposé par

Neoadjuvant and adjuvant nivolumab associated with irreversible electroporation in patients with early hepatocellular carcinoma and high risk of recurrence (NIVOLEP trial)jean philippe BORGES2026-08-26T17:30:01+02:00

Résultats de l’AAP Emergence 2026
Galerie
Résultats de l’AAP Emergence 2026

AAP_infos

Résultats de l’AAP Emergence 2026

Revivez la présentation de l'édition 2026 Support de

Résultats de l’AAP Emergence 2026jean philippe BORGES2026-07-07T16:09:14+02:00

Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy
Galerie
Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy

article du mois

Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapy

Article du mois de juillet 2026 spécial "Onco-Dermatologie" proposé

Melanoma cell states shape spatial tumor-immune ecosystems to dictate the efficacy of anti-PD1 immunotherapyjean philippe BORGES2026-08-26T17:30:19+02:00